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Abstract: Both the establishment of sustainable forestry practices and the improvement of
commercially grown trees require better understanding of mechanisms used by forest trees to
combat microbial pathogens. We investigated the contribution of a gene encoding Scots pine
(Pinus sylvestris L.) antimicrobial protein Sp-AMP2 (PR-19) to the host defenses to evaluate the
potential of Sp-AMP genes as molecular markers for resistance breeding. We developed transgenic
tobacco plants expressing the Sp-AMP2 gene. Transgenic plants showed a reduction in the size
of lesions caused by the necrotrophic pathogen Botrytis cinerea. In order to investigate Sp-AMP2
gene expression level, four transgenic lines were tested in comparison to control and non-transgenic
plants. No Sp-AMP2 transcripts were observed in any of the control and non-transgenic plants
tested. The transcript of Sp-AMP2 was abundantly present in all transgenic lines. Sp-AMP2
was induced highly in response to the B. cinerea infection at 3 d.p.i. This study provides an
insight into the role of Sp-AMP2 and its functional and ecological significance in the regulation
of plant–pathogen interactions.
Keywords: antimicrobial protein; plant-fungi interaction; plant defense; disease resistance;
heterologous expression; pathogenic fungus
1. Introduction
Plants engage an armory of defenses in response to microbial infection and pathogen attack.
Invasion of plant tissues by microorganisms causes large-scale rearrangements in host metabolism,
which are achieved via orchestrated changes in expression levels of hundreds of genes. Activation
of defense responses is mediated by several types of signaling molecules via specific signaling
pathways [1]. The best-characterized examples of such signaling molecules are jasmonic acid (JA)
and methyl jasmonate (MeJA), ethylene (ET), and salicylic acid (SA). The activation of corresponding
signaling pathways results in the induction of various plant defensive mechanisms, both physical
and chemical. Physical defensive mechanisms include, among others, suberization and reinforcement
of cell walls, and formation of wound periderm. Accumulation of induced antimicrobial secondary
metabolites collectively known as phytoalexins (terpenoids, tannins, stilbenes, alkaloids, etc.), oxidative
burst, and induction of antimicrobial and pathogenesis-related (PR) proteins provide examples of
plant chemical defenses [2,3]. Pathogen-inducible defense-related proteins, known as PR proteins,
have been reported in many plant species to enhance resistance of plants against microbial pathogens
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and insect pests [4]. Antimicrobial peptides (AMPs) play a major role in defense, and they are
considered to be an important component of the innate immunity in living organisms [5]. Plant
AMPs vary in their amino acid composition and structure [6] and are assigned to different families [7].
However, they share fundamental structural properties, such as small size and clustering of the cationic
and hydrophobic amino acids within distinct domains [8]. The correlation between the increased
production of antimicrobial peptides and improved pathogen resistance has been demonstrated in
many commercial species [9,10]. AMPs are considered to be an important tool for the enhancement
of the pest resistance in commercial crops, and there are numerous examples where heterologous
expression of plant AMPs resulted in increased resistance to pathogens [11]. However, most of the
AMPs studied so far originated from angiosperms, and the potential of AMPs from other plant groups
(e.g., conifers, ferns, or mosses) remains poorly investigated.
In conifers, pathogenesis-related proteins associated with the defensive responses to
Heterobasidion annosum (Fr.) Bref. infection include PR-2 (β-1,3-glucanases) [12], PR-3 (chitinases) [13,14],
PR-5 (thaumatin-like proteins) [15], PR-9 (class III peroxidases) [16,17], PR-12 (defensin PsDef1) [18],
SPI1 [19], and PR-19 (Scots pine antimicrobial proteins, Sp-AMPs) [20,21]. Other PR proteins induced
upon pathogen infections and diverse abiotic stress in forest tree species are implicated in the systemic
acquired resistance and tree resistance as well (as reviewed elsewhere [22]).
Five genes of Scots pine (Pinus sylvestris L.) antimicrobial peptides, Sp-AMPs, induced in response
to inoculation with H. annosum, have been identified, of which four (Sp-AMP1–4) are known to share
93–100% nucleotide sequence identity [20]. Sp-AMPs represent a family of PR proteins, PR-19. PR-19
is proposed to be a family of non-catalytic β-glucan binding proteins that inhibit the hyphal growth of
H. annosum [21]. Sp-AMP proteins are 105 amino acids-long cysteine-rich proteins, each containing an
N-terminal region with a predicted secretion signal peptide. Based on the structure, conserved number
and relative spacing of cysteines, Sp-AMP proteins belong to the MiAMP1 (Macadamia integrifolia
Maiden & Betche AMP) family of proteins [23], which are believed to have a role in the defense against
fungal pathogens. The proposed mode of action for these antimicrobial peptides involves interference
with glucan assembly and alteration of the fungal cell wall structure, consequently compromising the
fungal cell wall integrity [21]. Sp-AMP proteins’ applicability for the tree innate immune system is in
providing rapid host protection with low energy expense [24].
We explored an effect of the heterologous expression of the Sp-AMP2-encoding gene in the
angiosperm model plant tobacco. The main objective of expressing Sp-AMP2 was to evaluate the
potential role of Sp-AMP in plant resistance and to elucidate its functional significance in the regulation
of phytopathogen-host interaction. The response of the transgenic tobacco expressing Sp-AMP2
challenged with a fungal pathogen was investigated.
2. Materials and Methods
2.1. Agrobacterium Tumefaciens Vectors and Strains
Sp-AMP-encoding genes share a high level of sequence similarity. Sp-AMP2 has the
highest score for identity of the Sp-AMP consensus sequence among the other members [20].
The Sp-AMP2 full-length complementary DNA (cDNA) was obtained by PCR amplification
from a subtraction cDNA library (hasp001xd12f; GenBank: BI416519.1) of Scots pine root tissue
infected with the root rot fungus H. annosum. It was cloned into pT-Adv vector (Clontech,
Mountain View, CA, USA) using gene-specific primers containing XhoI and XbaI restriction sites and
twenty-four nucleotides representing the Strep-tag II sequences in the reverse primer (IBA, Göttingen,
Germany). The primers were designed based on the coding sequence of Sp-AMP2 gene (Genebank:
AF410953.1) (forward primer: 5′ GCACTCGAGATGGAAACCAAGCGCTTGGCAT; reverse primer:
5′-CAGTCTAGATCATTTTTCGAACTGCGGGTGGCTCCAGCATTGGATGAAAAAACT).
The amplified products were subcloned into the XhoI/XbaI-digested plant binary vector pE1801
where the NcoI site was first deleted by mung bean nuclease trimming and re-ligation. pE1801 (Figure 1)
Forests 2018, 9, 10 3 of 15
contains a T-DNA segment that includes the kanamycin resistance gene nos-nptII, as well as strong
synthetic promoter, the “super promoter” [25]. Cloning into the binary vector pE1801 was confirmed
by sequencing. Recombinant construct was used to transform Agrobacterium tumefaciens Smith &
Townsend strain EHA105 by freeze-thaw method [26]. A single colony of the A. tumefaciens EHA105
strain harboring the pE1801 and growing on LB agar plates supplemented with 100 mg/L kanamycin
(Sigma-Aldrich, St Louis, MO, USA) and 100 mg/L rifampicin (Sigma-Aldrich, St Louis, MO, USA)
was used to inoculate 5 mL of LB medium. After overnight incubation at 28 ◦C, 220 rpm, 5 mL of the
bacterial culture was added to 30 mL MS (Murashige and Skoog Basal Salt Mixture) liquid medium
(Sigma-Aldrich, M5524, St Louis, MO, USA) [27]. The resulting Agrobacterium suspension was used for
tobacco transformation.
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shadowed amino acids show the peptide sequence of Sp‐AMP2 protein, grey shadowed amino acids 
show  the  Strep‐tag  II.  (b) Map  of  the  T‐DNA  binary  vector  pE1801. Cassette,  pMSP‐2, with  the 
Translational (TL) enhancers element from Tobacco Etch Virus (TEV); Pnos, nos promoter; tAg7, poly 
(A)  addition  signal  for  T‐DNA  gene  7;  nptII,  gene  conferring  resistance  to  kanamycin; Aocs,  ocs 
transcriptional activating element; AmasPmas, mas2′ activating and promoter elements; ags‐ter, poly 
(A)  addition  signal  from  the  agropine  synthase  gene,  LB  and RB,  left  and  right  border  sequences 
delimiting T‐DNA. Restriction endonuclease sites within parentheses are not unique to the plasmid. 
Figure 1. Sequences of the amino acids an the nucleotides of the signal peptide of Sp-AMP2. (a) Red
shadowed amino acids show the peptide sequence of Sp-AMP2 protein, grey shadowed amino acids show
the Strep-tag II. (b) Map of the T-DN binary vector pE1801. Cassette, pMSP-2, with the Translational
(TL) enhancers element from Tobacco Etch Virus (TEV); Pnos, nos promoter; tAg7, poly (A) addition signal
for T-DNA gene 7; nptII, gene conferring resistance to kanamycin; Aocs, ocs transcriptional activating
element; AmasPmas, mas2′ activating and promoter elements; ags-ter, poly (A) addition signal from
the agropine synthase gene, LB and RB, left and right border sequences delimiting T-DNA. Restriction
endonuclease sites within parentheses are not unique to the plasmid. (c) Original pE1801 map before
modification (NcoI site was deleted) which shows restriction sites relevant for cloning.
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2.2. Tobacco Transformation
Tobacco (Nicotiana tabacum L. cv. Petit Havana SR1) was stably transformed using the leaf disc
method [28]. Leaves were surface-sterilized for 1 min with 70% ethanol and for 10 min with 1.2%
sodium hypochlorite solution, then rinsed five to seven times with sterile water.
The Agrobacterium suspension and tobacco leaf discs were incubated in a petri dish for 5 min, then
infected leaf discs were placed upside down on agar-solidified MS medium (Sigma-Aldrich, M5524,
St Louis, MO, USA) containing 1 mg/L BAP (6-benzylaminopurine, Sigma-Aldrich, M5524, St Louis,
MO, USA) and supplemented with sucrose (20 g/L) (Sigma-Aldrich, M5524, St Louis, MO, USA).
Plates were kept in the dark for 2 days; thereafter the infected explants were transferred to a fresh
solid MS medium containing 1 mg/L BAP and sucrose (20 g/L), and supplemented with 100 mg/L
kanamycin and 500 mg/L cefotaxime (Sigma-Aldrich, M5524, St Louis, MO, USA) at 23 ◦C in the light
for 4–6 weeks. Each week, fresh selection plates were changed and, after the emergence of the shoots,
a single shoot per leaf disc was transferred to MS Jars containing 100 mg/L kanamycin and 500 mg/L
cefotaxime. Transgenic plants were regenerated under kanamycin selection and plantlets were moved
into vermiculite in the growth room and then to the green house. Seeds (T1 generation) from the
transgenic lines (T0) were collected after self-pollination. For pathogen resistance assay, the wild type
plant (control) and four independently transformed T1 lines and their segregating siblings were used.
2.3. Selection of Transgenic Plants
The T1 seeds from transgenic plants were surface-sterilized by immersion in 70% (v/v) ethanol
for 2 min, followed by immersion in 1.2% sodium hypochlorite solution for 10 min. Afterwards, seeds
were washed four times with sterile distilled water and sown onto 1% agar-containing MS medium
supplemented with kanamycin (100 mg/L) and sucrose (20 g/L). Plates were incubated at 18 ◦C with
a photoperiod of 16 h. After 14 days, the well-developed rooted seedlings were transferred to soil
prepared by mixing peat (Kekkilä Horticulture Peat, Kekkilä Oyj, Finland) and washed sand at a 5:1
ratio (v/v). T1 transgenic and non-transgenic plants were generated and sorted based on PCR analysis
(XP cycler, BIOER, Hangzhou, China); the PCR product was absent in non-transgenic plants. All plants
were grown in a growth room under controlled conditions, were watered when needed, and fertilized
weekly with a 1.0% solution of N/P/K (8:4:6 or 16:9:22) fertilizer (Yara, Espoo, Finland).
2.4. cDNA Synthesis by Reverse Transcription
For the initial verification of Sp-AMP2 in the transgenic plants, RNA was extracted from one
T0 transgenic plant, one T1 transgenic plant, one T1 non-transgenic, and one wild type control
plant according to the methods of Chang et al. [29]. RNA concentration and quality were assessed
spectrophotometrically using a NanodropTM ND-1000 (NanoDrop Technologies, Wilmington, DE,
USA). A 1 µg sample of each total RNA isolate was used for cDNA synthesis, as described by Jaber
et al. [30]. To verify the transcript of Sp-AMP2 in the tested tobacco plants, the resulting cDNA was
diluted (1:5) and 5 µL was used to amplify the Sp-AMP2 fragment. The PCR products were separated
on a 1.5% agarose gel.
2.5. Pathogen Bioassays of Transgenic Plants
Botrytis cinerea Pers. isolate B05.10 [31], a haploid aggressive strain isolated from Vitis vinifera
L. (kindly provided by Mehmet Ali Keçeli, Department of Biosciences, Faculty of Biological and
Environmental Sciences, University of Helsinki) was used for the pathogen assay.
B. cinerea was grown on potato-carrot agar (PCA). PCA was prepared as follows: 300 g of diced
potatoes and 25 g of diced carrots were boiled in water for 30 min, then mashed and filtered through
Miracloth (Millipore, Billerica, MA, USA). The final volume was adjusted to 1 L with H2O, and 15 g of
agar was added. B. cinerea was grown for 10 days in the dark at approximately 22 ◦C. Spores were
harvested from each dish by rinsing with 10 mL PDB (Potato Dextrose Broth, Difco, Detroit, MI, USA)
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while agitating the colonies gently with a glass rod. The spores in PDB medium were vortexed for
10 min at maximum speed and then filtered through Miracloth. The concentration of B. cinerea spores
was adjusted to 1 × 106 spores/mL. Four-week-old T1 generation tobacco plants and non-transformed
control plants were inoculated with 10 µL of the spore suspension of B. cinerea onto the upper surface of
a leaf of the growing seedling. Wild type plants (control) and four T1 lines were tested; five plants per
line including four transgenic T1 plants and one non-transgenic T1 plant were used for each treatment
and evaluated for disease development. To determine the susceptibility of plants, disease lesions
were scored at 3 and 5 days post-inoculation (d.p.i.) and recorded using an optical Olympus CX31
microscope equipped with a digital Olympus SC30 camera (Olympus, Tokyo, Japan).
2.6. PCR Analysis of Transgenic Plants
Genomic DNA was isolated using a CTAB (cetyl trimethylammonium bromide) method [32].
The genomic DNA samples of the control plants and transformed T0 lines were analyzed by PCR
(XP cycler, BIOER, Hangzhou, China) with the same primers that were used for cloning. The size of
the amplified product matched the predicted length of 358 bp. Amplification was performed under
the following conditions: 95 ◦C for 5 min, 39 cycles of 94 ◦C for 30 s, 62 ◦C for 30 s, and 72 ◦C for 40 s.
Finally, the PCR products were separated on a 1.5% agarose gel and visualized by ethidium bromide
staining. Segregating T1 lines were tested using PCR to verify segregating transgenic plants.
2.7. Real-Time Quantitative PCR Analysis
The analysis of the expression levels of the Sp-AMP2 and marker genes for the SA/JA/ET signaling
pathways was performed by real-time quantitative reverse transcription PCR (qRT-PCR, LightCycler®
480 II system, Roche Diagnostics, Basel, Switzerland). For this purpose, RNA was extracted from
transgenic, non-transgenic, and control plants. For each of the mentioned plant lines, 100 mg of
non-treated young leaves (control), leaves inoculated with 10 µL of PDB (mock inoculation), and leaves
inoculated with 10 µL of the spore suspension of B. cinerea (treatment) were taken for RNA isolation.
cDNA synthesis by reverse transcription was preformed according to the protocol described above.
qRT-PCR was performed with the LightCycler® 480 II system (Roche Diagnostics, Basel,
Switzerland) according to the manufacturer’s instructions. The list of gene names, accession numbers,
qRT-PCR primers, and product sizes is provided in Supplementary file S1. PCR thermal conditions
consisted of initial denaturation at 95 ◦C for 10 min followed by 40 cycles of 95 ◦C for 15 s and 1 min at
the appropriate annealing temperature. The specificity of the primer pairs was verified both by gel
and by melting curve analysis. The transcript abundance was estimated with LightCycler software
version 3.5 (Roche) using SYBR® Green PCR Master Mix (Invitrogen) according to the manufacturer's
recommendations, based on three biological and three technical replicates for each gene. The gene
for elongation factor 1a (EF-1a), a very stably expressed gene [33], was used as a reference gene.
In agreement with the previous reports, the expression level of this gene showed very little variation in
our experiments (mean cycle threshold (Ct) value Ct ± SE = 26.91 ± 0.03, n = 324, where SE indicates
standard error). The raw Ct values of the tested genes were normalized to the reference gene and used
to compare the results from untreated control wild type against all samples using the 2−∆∆Ct method,
as described previously [34].
2.8. Statistical Analyses
All experiments were repeated three times, and similar results were obtained. Means and standard
errors were estimated from three independent experiments. Error bars indicate the standard error
of the mean across three biological replicates. Statistical significance analyses of the necrosis were
performed using paired t-test as well as by two-way ANOVA test. Bonferroni post hoc test was
applied on the data to compare the value of each column factor “necrosis length” and each row
factor “Genotype”. p > 0.05 was considered to be non-significant (Supplementary file S2). Statistical
significance of the pathogen assays on transgenic plants and the gene expression were calculated by
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two-way ANOVA test. Thereafter, Bonferroni post hoc test correction was applied on the data for
comparisons. The threshold for fold changes in the expression of the differentially expressed genes in
comparison to the control samples was set at 2-fold. Asterisks indicate the significance of differences,
* p values < 0.05, ** p values < 0.01, and *** p values < 0.001.
3. Results
3.1. Generation of Sp-AMP2 Transgenic Tobacco Plants
The Scots pine Sp-AMP2 cDNA under control of a strong promoter was introduced into tobacco
(Nicotiana tabacum cv. Petit Havana SR1) by Agrobacterium tumefaciens-mediated transformation method
(Figure 1). The promoter in the vector is a chimeric promoter derived from the octopine and mannopine
synthase genes that is approximately 156-fold stronger than the cauliflower mosaic virus (CaMV)
35S promoter in tobacco leaf tissue, which makes it useful for high level constitutive expression of
genes [25]. Presence of the Sp-AMP2 gene in the genomic DNA of tobacco plants was confirmed by
PCR amplification. A 358 bp DNA fragment was detected in T0 transgenic tobacco lines, whereas
no bands were detected in the untransformed control tobacco plant (Figure 2a). Four different tested
tobacco lines T0 were selected for T1 seed collection after self-pollination, and used for further analysis.
T1 seeds were collected and verified for transgene presence in plants regenerated on selective medium
by PCR (Figure 2b). Transcription of Sp-AMP2 was confirmed by PCR amplification of SpAMP2-specific
fragments from the cDNA of the non-transformed wild type, T0, non-transgenic and transgenic T1
plants (Figure 3). The T0 and T1 transgenic lines showed the transcript abundance of Sp-AMP2.
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Figure 2. PCR analysis of DNA isolated from transgenic and control tobacco lines. (a) Fragment of
358 bp was generated from T0 plants using Sp-AMP2-specific primers. Four lines were selected to
generate T1 lines (underlined). Lanes 2–12: T0 transgenic tobacco lines; lane C: non-transformed tobacco
(control); lane M: 100 bp DNA ladder. (b) Fragment of 358 bp was generated from T1 plant using
Sp-AMP2-specific primers. Upper gel: lane 1: segregating T1 line 4 tobacco plant; lanes 2–7: segregating
T1 line 3 tobacco plants; lanes 8–13: segregating T1 line 2 tobacco plants; lane 14: no template DNA
(water); lane PC: plasmid pE1801-Sp-AMP (positive control); lane C: non-transformed tobacco (negative
control); lane M: 100 bp DNA ladder. Lower gel: lane M: 100 bp DNA ladder; lanes 1–7: segregating T1
line 9 tobacco plants; lane 8: no template DNA (water); lane PC: plasmid pE1801-Sp-AMP (positive
control); lane C: non-transformed tobacco (control); lane M: 100 bp DNA ladder.
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lane M: 100 bp ladder. 
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The effects of infection caused by B. cinerea were investigated on the T1 transgenic plants and 
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Figure 3. Analysis of the Sp-AMP2 gene expression in the transgenic tobacco plants by amplification
of the gene-specific product from cDNA. Lane 3–2: transgenic T1 plants; lane 2–5: non-transgenic T1
plants; lane 9: T0 plants; lane C: control non-transgenic plants; lane NC: PCR without DNA template;
lane M: 100 bp ladder.
3.2. Sp-AMP2-Transformed Tobacco Plants Show Increased Tolerance to B. cinerea
The effects of infection caused by B. cinerea were investigated on the T1 transgenic plants and
compared with both non-transformed plants and their non-transgenic segregating siblings. The T1
plants were verified by rooting in selective media and PCR. Each transformation event comprising
of three transgenic T1 plants was compared to two non-transgenic T1 sibling plants and to one
non-transformed control plant. The sizes of the lesions determined from 3 to 5 days post-inoculation
(d.p.i.) under conditions described in the material section are indicated in Figure 4. Necrotic lesions
caused by B. cinerea on the control tobacco and non-transgenic T1 leaves were more severe and larger
than those formed on the leaves of T1 transgenic lines. The lesions on the transgenic lines usually
increased slightly after 2 extra days of incubation, however, none reached the same size as those in the
non-transformed control. Transgenic tobacco showed significant difference in lesion size in response
to infection by B. cinerea as compared to the non-transgenic in the two time points (Supplementary
file S3). Similar levels of lesion development were observed on non-transgenic T1 plants, compared
to those of control plants. However, the disease spread was slower on transgenic plants (Figure 4).
No statistically significant differences in the size of necrotic lesions were observed among different
transgenic lines expressing the Sp-AMP2 gene.
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3.3. Expression Profiles of Sp‐AMP2 Gene and SA/JA/ET Gene Markers in Transgenic Plants 
In  order  to  investigate  Sp‐AMP2  gene  expression  level,  four  transgenic  lines were  tested  in 
comparison to control and non‐transgenic plants. No Sp‐AMP2 transcripts were observed in any of 
the control and non‐transgenic plants tested. The transcript of Sp‐AMP2 was abundantly present in 
all transgenic lines. Sp‐AMP2 was induced highly in response to the B. cinerea infection at 3 d.p.i. in 
the  three  transgenic  lines  (except  for  line  4)  and  the  expression was  sustained  over  time by  the 
pathogen (5 d.p.i) (Figure 5). 
Figure 4. Disease evaluation in Sp-AMP2-transgenic tobacco plants. (A) Left to right: leaf surface of
non-transgenic tobacco with no infection (R); spores inoculation symptoms caused by B. cinerea on a
leaf surface of transgenic tobacco 3 days post-inoculation (Sp-AMP); spores inoculation symptoms
caused by B. cinerea on a leaf surface of non-transgenic tobacco 3 days post-inoculation (N). (B) Size of
lesions (indicated with red arrows) formed in leaves 3 days after inoculation with B. cinerea on wild
type (C) and transgenic plants (T1). (C) Size of lesions progressed in leaves 5 days after inoculation with
B. cinerea on the same plants. (D) Analysis of lesion sizes on transgenic lines T1 leaves overexpressing
Sp-AMP2 inoculated with B. cinerea compared to non-transgenic T1 and wild type plants (control).
Error bars indicate the standard error of the mean across three biological replicates. Letters indicate
statistically significantly different groups identified by ANOVA analysis (p < 0.001).
3.3. Expression Profiles of Sp-AMP2 Gene and SA/JA/ET Gene Markers in Transgenic Plants
In order to investigate Sp-AMP2 gene expression level, four transgenic lines were tested in
comparison to control and non-transgenic plants. No Sp-AMP2 transcripts were observed in any of the
control and non-transgenic plants tested. The transcript of Sp-AMP2 was abundantly present in all
transgenic lines. Sp-AMP2 was induced highly in response to the B. cinerea infection at 3 d.p.i. In the
three transgenic lines (except for line 4) and the expression was sustained over time by the pathogen
(5 d.p.i) (Figure 5).
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Figure 5. Quantitative real-time PCR analysis of expression patterns of Sp-AMP2 in different tissues and
in response to vari us treatments at 3 and 5 days post-inoculation. Sp-AMP2 relative expression levels
wer determin d as describe arlier (Livak and Schmittgen 2001 [34]) and normalized with Elongation
factor 1a (EF-1a). WT-M, untransformed wild-type tobacco mock treated with PDB (Potato Dextrose
Broth); WT-B, untransformed wild-type tobacco infected with B. ciner a; NT-C, non-transgenic tobacco
not treated control; NT-M, non-transgenic tobacco mock treated with PDB; NT-B, non-transgenic
tobacco with independent ra sgenic tobacco inf cted with B. ciner a; Line 2; L 3; Li e 4; i 9,
independent tra sgenic li e expressing Sp-AMP2 with either non-treated co trol (C), infected with
B. cinerea (B), or mock treated with PDB (M). Data represent he fold chang f Sp-AMP compared
with expression in untreated wild typ control plants at the corresponding time po ts. Error bar
indicate the standard rror of the mean across three independ nt biological replicates. Asterisk
indicate the level of significance in compariso to non-transgenic plants inf cted with B. cinerea (NT-B),
*** p v lues < 0.001.
To study the interaction between the SA and JA/ET signaling pathways and the expression of
Sp-AMP2 in the transgenic tobacco, we investigated the expressions levels of two important marker
genes. PR1a is a SA-associated gene that serves as a common indicator for SA signaling pathway
activity [35]. ERF1 (ethylene response factor 1) is a marker gene, which is induced by simultaneous action
of the JA and ET signaling pathways [36]. The induction of ERF1 was observed in all tested tobacco
plants at 3 d.p.i. However, increased levels of ERF1 transcripts were observed in the transgenic plants,
notably in two lines challenged with B. cinerea (Lines 3 and 9) (Figure 6). PR1a was strongly induced in
the mock-inoculated wild type and in two transgenic lines (Lines 4, 9). The highest expression was
observed in the transgenic line 9 (Figure 6).
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with PDB (M). Data represent the fold change of Sp‐AMP compared with expression in untreated wild 
type control plants at  the corresponding  time points. Error bars  indicate  the standard error of  the 
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4. Discussion 
In the present study, we investigated the role of a gene encoding Scots pine antimicrobial peptide 
Sp‐AMP2  in  the  defense  against  pathogenic  fungi.  Our  earlier  results  showed  strong  Sp‐AMP 
induction  in  Scots  pines  challenged with  the  necrotrophic  fungal  pathogen H.  annosum  [20,21], 
justifying further detailed functional analyses of the corresponding gene. A successful transfer of a 
Sp‐AMP2‐encoding gene of the gymnosperm (Scots pine) to the angiosperm recipient (tobacco) was 
Figure 6. Transcript abundance of tobacco PR1a (above) and ERF1 (belo ) genes in different tobacco
plants at 3 and 5 days post-inoculation with either non-treated control (C), either infected with B. cinerea
(B), or mock treated with PDB (M). PR1a and ERF1 relative expression levels were determined
as described earlier (Livak and Schmittgen 2001 [34]) and normalized with Elongation factor 1a
(EF-1a). WT-M, untransformed wild-type tobacco mock treated with PDB; WT-B, untransformed
wild-type tobacco infected with B. cinerea; NT-C, non-transgenic tobacco non-treated control; NT-M,
non-transgenic tobacco mock treated with PDB; NT-B, non-transgenic tobacco with independent
transgenic tobacco infected with B. cinerea; Line 2; Line 3; Line 4; Line 9, independent transgenic line
expressing Sp-AMP2 with either non-treated control (C), infected with B. cinerea (B). or mock-treated
with PDB (M). Data represent the fold change of Sp-AMP compared with expression in untreated wild
type control plants at the corresponding time points. Error bars indicate the standard error of the mean
across three independent biological replicates. Asterisks indicate the level of significance in comparison
to non-transgenic plants infected with B. cinerea (NT-B), *** p values < 0.001.
4. iscussion
In the present study, we investigated the role of a gene encoding Scots pine anti icrobial peptide
Sp-A P2 in the defense against pathogenic fungi. Our earlier results showed strong Sp-AMP induction
in Scots pines challenged with the necrotrophic fungal pathogen H. annosum [20,21], justifying further
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detailed functional analyses of the corresponding gene. A successful transfer of a Sp-AMP2-encoding
gene of the gymnosperm (Scots pine) to the angiosperm recipient (tobacco) was demonstrated. No
homologs of Sp-AMP genes have been identified either in Nicotiana benthamiana Domin or in Nicotiana
tabacum [37]. Our results suggest that expression of Sp-AMP2 in transgenic tobacco conferred enhanced
resistance to Botrytis cinerea. This is a further functional demonstration of the potential role of Sp-AMP2
in plant defense. The plants expressing Sp-AMP2 showed a reduction in the spread and subsequent
expansion of fungal infection over the 5 day evaluation period, with the most significant statistical
differences being observed at 5 d.p.i., indicating that Sp-AMP2 is actively involved in the inhibition of
B. cinerea and suggesting a broader spectrum of the Sp-AMP2 inhibitory activity. The observed delay
in symptom development could potentially allow plants either to recover or adapt to changes in field
conditions that could potentially reduce disease spread.
A considerable variation in the expression level of the heterologous Sp-AMP2 gene among
different lines of transgenic tobacco plants was observed in our experiments. The reasons for these
differences are not entirely clear, as the gene was put under control of a strong constitutive promoter.
One of the possible explanations could be the integration of the transgenic construct in different
genomic loci of the transgenic host plants, which in turn might have an effect on the expression level
of the transgene. However, the transgenic lines with different expression levels of the Sp-AMP2 gene
showed no statistically significant differences in the size of necrotic lesions caused by inoculation with
B. cinerea. It is likely that even low-level expression of Sp-AMP2 is sufficient to protect transgenic
tobacco plants from this fungal pathogen.
Tobacco plants expressing Sp-AMP2 showed increased level of ERF1 induction upon pathogen
challenge, indicating a potential interplay between Sp-AMP expression and JA/ET signaling pathways.
In Scots pine, increased expression of Sp-AMP in response to pathogen challenge, salicylic acid,
ethylene, and other environmental stresses was shown in our earlier study [21]. SA-dependent
signaling pathway, which is engaged with the cell death machinery against biotrophic pathogens,
controls the synthesis of low molecular weight antimicrobial proteins such as PR-1, PR-2, and PR-5.
At the same time, the JA/ET-dependent pathway is associated with defense against necrotrophic
pathogens, and it activates genes that encode antimicrobial proteins such as thionin (THI2.1), defensin
(PDF1.2), PR-3, and PR-4 [38]. Such differences may affect the specificity of plant-pathogen interactions.
PR-19 family members are potential alternatives to current H. annosum control and management
strategies, since they exploit built-in defense systems of the host trees. A long-term objective is to find
a gene that is tightly linked to a disease resistance trait that would serve as molecular DNA marker
to be applied in breeding programs and facilitate the selection of naturally occurring genotypes with
higher resistance against the root rot pathogen.
A similar cysteine-rich peptide, MiAMP1 protein, has been shown to be highly inhibitory to a
wide range of phytopathogens, particularly fungi. In addition, transgenic expression of MiAMP1 in
canola (Brassica napus L.) provided enhanced resistance against blackleg disease caused by the fungus
Leptosphaeria maculans Ces. & De Not [39]. Also, another MiAMP1-related cysteine-rich antimicrobial
peptide from western white pine (Pinus monticola Douglas ex D. Don) (PmAMP1) that belongs to the
same family of MiAMP1, and is the closest homolog to Sp-AMPs, has been successfully transformed
into canola and proved to confer resistance to multiple fungal pathogens (Alternaria brassicae (Berk.)
Sacc., L. maculans, and Sclerotinia sclerotiorum (Lib.) de Bary) [40]. Further genetic association studies on
western white pine PmAMP1 in a collection of western white pine trees revealed that high quantitative
disease resistance against white pine blister rust (WPBR) caused by the obligate biotrophic fungus
Cronartium ribicola A. Dietr. is genetically attributed (albeit slightly) to multiple PmAMP1 haplotypes,
suggesting that functional regulation of many other defense-related genes is contributing to the
quantitative variations of disease resistance. However, the study identified a haplotype of PmAMP1
(PmAMP1- hap2) which confers a higher resistance to C. ribicola than other haplotypes and which
would therefore certainly benefit traditional tree breeding by marker-assisted selection [41].
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The cysteine-rich antimicrobial peptides are evolutionarily dynamic within plant genomes, which
are highly adaptive in the challenge of more evolutionary flexible pathogen populations [42]. Moreover,
the structural resemblance between MiAMP1 protein family members and the novel Sp-AMP does
not necessarily reflect functional similarities [43]. Therefore, the functional validation of the novel
Sp-AMPs from the Scots pine through this transgenic experiment is imperative to manifest its potential
in plant disease immunity.
Other authors have also demonstrated that somatic embryos of Norway spruce (Picea abies
(L.) H. Karst.) plants at an age of 8 to 10 months over-expressing the SPI1 spruce defensin
protein displayed reduced fungal growth in the sapwood after inoculation with H. annosum [44].
Also, SPI1 spruce defensin that was expressed in tobacco permitted less growth of the bacterial
pathogen Erwinia carotovora (Jones) Bergey et al. [45], suggesting that SPI1 increases resistance
in both homologous and heterologous systems. Furthermore, poplar trees transformed with
a gene encoding synthetic peptide D4E1 were found to be resistant to bacterial pathogens
Agrobacterium tumefaciens and Xanthomonas populi (Ridé) van den Mooter & Swings but not to the
fungal pathogen Hypoxylon mammatum (Wahlenb.) P. Karst [46].
The combination of the broad spectrum action of MiAMP1 protein family members on numerous
microorganisms [47,48] and the nature of the cysteine-rich AMPs, which reduce the growth of major
microbes without any toxic effects toward the host [49], makes Sp-AMP proteins potential candidates
for developing pathogen-resistant crops, a further demonstration of their role in tree resistance.
5. Conclusions
In this study, in order to address the role of Sp-AMPs in plant defense, Sp-AMP2 was inserted
into the genome of the tobacco model plant. The transformed tobacco plants with Sp-AMP2 showed
increased tolerance against Botrytis cinerea. Our future study will explore the possibility to transfer
the Sp-AMP2 into a related conifer tree species using most promising technology approaches [50] and
further assess its role in tree resistance.
Supplementary Materials: The following are available online at www.mdpi.com/1999-4907/9/1/10/s1,
Supplementary file S1: List of primers used for the real-time quantitative PCR assays, Supplementary file
S2: Statistical significance analyses of the genes expression, Supplementary file S3: Statistical significance analyses
of the lesion size.
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